Event Cardio Group Inc. (ECGI) 0.0783 $ECGI
Event Cardio Group Completes First $500,000 of $2,000,000 BreastCare DTS(TM) Distribution Agreement for Southern Asia
Marketwire Canada - Tue Apr 28, 3:00PM CDT
Event Cardio Group, Inc. (www.eventcardiogroup.com) (OTCQB: ECGI), a medical device company specializing in the detection and preventive treatment of high-risk diseases, is pleased to announce it has received the final $300,000 thereby completing the initial $500,000 stage of the $2,000,000 licensing agreement with MedPac Asia Pacific PTY Ltd, of Australia. MedPac received a Convertible Promissory Note and was granted the exclusive distribution rights for both BreastCare DTS(TM) and NowCardio(TM) products in their exclusive territory -- Australia, New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Laos, Cambodia, Myanmar and Bangladesh. With the Philippines having the highest breast cancer mortality rate among the countries listed, the immediate focus will be to use pre-existing distribution channels to make the BreastCare DTS(TM) device available for consumers.
Event Cardio Group, Inc. Completes Next Step in Production of FDA-510k Cleared BreastCare DTS Device
Marketwire Canada - Wed Apr 22, 3:00PM CDT
Event Cardio Group, Inc. (www.eventcardiogroup.com) (OTCQB: ECGI), a medical device company specializing in the detection and preventive treatment of high-risk diseases, is pleased to announce that Ceres Technologies, based in Saugerties, New York, (www.cerestechnologies.com) has begun manufacturing the BreastCare DTS(TM) device. With production of units underway the FDA Code of Federal Regulations Title 21 required filing for Good Manufacturing Practices is in process.
Event Cardio Group Signs $8,000,000 Investment Term Sheet With a Hong Kong Corporation
Marketwire Canada - Wed Mar 18, 3:00PM CDT
Event Cardio Group, Inc. (OTCQB: ECGI), a medical device company that specializes in the detection and preventive treatment of high-risk diseases, is pleased to announce it entered into an Investment Term Sheet with R.J. Capital Management, Ltd. The term Sheet calls for an investment of $4,000,000 for 20% of Event Cardio Group and an additional $4,000,000 contribution by R. J. Capital towards a joint venture which will have exclusive distribution and manufacturing rights for Event Cardio Group's FDA approved Breast Care DTS(TM) in China.
Event Cardio Group Closes First Tranche of $2,000,000 BreastCare DTS(TM) Distribution Agreement for Southern Asia
Marketwire Canada - Mon Mar 09, 3:00PM CDT
Event Cardio Group, Inc. (OTCQB: ECGI), a medical device company that specializes in the detection and preventive treatment of high-risk diseases, is pleased to announce it has completed the initial $500,000 stage of a $2,000,000 licensing agreement with MedPac Asia Pacific PTY Ltd, of Australia. MedPac invested $500,000 in Event Cardio Group for which it received a Convertible Promissory Note and was granted the exclusive distribution rights for both BreastCare DTS(TM) and NowCardio(TM) products in their exclusive territoriy -- Australia, New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Laos, Cambodia, Myanmar and Bangladesh. With the Philippines having the highest breast cancer mortality rate among the countries listed, the immediate focus will be to use pre-existing distribution channels to make the BreastCare DTS(TM) device available for consumers.
Event Cardio Group Acquires Worldwide Rights to Now Cardio(TM), Advanced Cardiac Monitoring Device
Marketwired - Wed Nov 19, 4:10PM CST
Event Cardio Group, Inc. (OTCQB: ECGI), a medical device company, announced it has finalized its acquisition of full intellectual property (IP) and development rights for Now Cardio(TM), advanced cardiac monitoring device.
Event Cardio Group Completes First $500,000 of $2,000,000 BreastCare DTS(TM) Distribution Agreement for Southern Asia
Marketwire Canada - Tue Apr 28, 3:00PM CDT
Event Cardio Group, Inc. (www.eventcardiogroup.com) (OTCQB: ECGI), a medical device company specializing in the detection and preventive treatment of high-risk diseases, is pleased to announce it has received the final $300,000 thereby completing the initial $500,000 stage of the $2,000,000 licensing agreement with MedPac Asia Pacific PTY Ltd, of Australia. MedPac received a Convertible Promissory Note and was granted the exclusive distribution rights for both BreastCare DTS(TM) and NowCardio(TM) products in their exclusive territory -- Australia, New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Laos, Cambodia, Myanmar and Bangladesh. With the Philippines having the highest breast cancer mortality rate among the countries listed, the immediate focus will be to use pre-existing distribution channels to make the BreastCare DTS(TM) device available for consumers.
Event Cardio Group, Inc. Completes Next Step in Production of FDA-510k Cleared BreastCare DTS Device
Marketwire Canada - Wed Apr 22, 3:00PM CDT
Event Cardio Group, Inc. (www.eventcardiogroup.com) (OTCQB: ECGI), a medical device company specializing in the detection and preventive treatment of high-risk diseases, is pleased to announce that Ceres Technologies, based in Saugerties, New York, (www.cerestechnologies.com) has begun manufacturing the BreastCare DTS(TM) device. With production of units underway the FDA Code of Federal Regulations Title 21 required filing for Good Manufacturing Practices is in process.
Event Cardio Group Signs $8,000,000 Investment Term Sheet With a Hong Kong Corporation
Marketwire Canada - Wed Mar 18, 3:00PM CDT
Event Cardio Group, Inc. (OTCQB: ECGI), a medical device company that specializes in the detection and preventive treatment of high-risk diseases, is pleased to announce it entered into an Investment Term Sheet with R.J. Capital Management, Ltd. The term Sheet calls for an investment of $4,000,000 for 20% of Event Cardio Group and an additional $4,000,000 contribution by R. J. Capital towards a joint venture which will have exclusive distribution and manufacturing rights for Event Cardio Group's FDA approved Breast Care DTS(TM) in China.
Event Cardio Group Closes First Tranche of $2,000,000 BreastCare DTS(TM) Distribution Agreement for Southern Asia
Marketwire Canada - Mon Mar 09, 3:00PM CDT
Event Cardio Group, Inc. (OTCQB: ECGI), a medical device company that specializes in the detection and preventive treatment of high-risk diseases, is pleased to announce it has completed the initial $500,000 stage of a $2,000,000 licensing agreement with MedPac Asia Pacific PTY Ltd, of Australia. MedPac invested $500,000 in Event Cardio Group for which it received a Convertible Promissory Note and was granted the exclusive distribution rights for both BreastCare DTS(TM) and NowCardio(TM) products in their exclusive territoriy -- Australia, New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Laos, Cambodia, Myanmar and Bangladesh. With the Philippines having the highest breast cancer mortality rate among the countries listed, the immediate focus will be to use pre-existing distribution channels to make the BreastCare DTS(TM) device available for consumers.
Event Cardio Group Acquires Worldwide Rights to Now Cardio(TM), Advanced Cardiac Monitoring Device
Marketwired - Wed Nov 19, 4:10PM CST
Event Cardio Group, Inc. (OTCQB: ECGI), a medical device company, announced it has finalized its acquisition of full intellectual property (IP) and development rights for Now Cardio(TM), advanced cardiac monitoring device.
